Showing 8481-8490 of 10903 results for "".
Rebooting the C. acnes Narrative
https://practicaldermatology.com/topics/acne-rosacea/rebooting-the-ic-acnesi-narrative/23623/A Practical Guide to Modern Melasma Treatment
https://practicaldermatology.com/topics/pigmentary-disorders/a-practical-guide-to-modern-melasma-treatment/67256/Modern management of melasma requires an individualized approach with targeted therapies that incorporate updated knowledge of disease pathogenesis.How Much Are You Leaving on the Table?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-leaving-on-the-table/21444/How to improve your after-tax financial efficiency for 2014.GLP-1-based Therapy and Hair Loss
https://practicaldermatology.com/issues/september-2026/glp-1-based-therapy-and-hair-loss/70057/Dermatologists must be prepared to manage effects of popular weight-loss therapies.Emollient-Based Therapy for AD: A Potential Role for Rebalancing the Microbiome
https://practicaldermatology.com/issues/supplements/emollient-based-therapy-for-ad-a-potential-role-for-rebalancing-the-microbiome/23136/Intergenerational Dermatology Practice: Two Generations of Dermatologists Reflect on the Field
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatology-practice-two-generations-of-dermatologists-reflect-on-the-field/23880/--Hispanic Home Remedies (remedios caseros) in the Management of Dermatologic Disease: A Focused Review
https://practicaldermatology.com/columns/clinical-focus-1/hispanic-home-remedies-iremedios-caserosi-in-the-management-of-dermatologic-disease-a-focused-review/23718/Chamomile, aloe vera, green tea, honey, and apple cider vinegar are popular remedios caseros.Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-43/23860/Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.